首页> 外国专利> PHARMACEUTICAL PARENTAL COMPOSITION COMPONENT CONTAINING SODIUM PARECOXIB, INJECTABLE SOLUTION AND SEALED VIAL UNDERSTANDING THE SAME

PHARMACEUTICAL PARENTAL COMPOSITION COMPONENT CONTAINING SODIUM PARECOXIB, INJECTABLE SOLUTION AND SEALED VIAL UNDERSTANDING THE SAME

机译:包含帕罗昔布钠,可注射溶液和密封的小瓶的药物学家长组成成分

摘要

"reconstitutable parenteral composition containing a cox-2 inhibitor". A pharmaceutical composition comprises, in powder form, (a) at least one water-soluble therapeutic agent selected from selective cox-2 inhibitory drugs and prodrugs and salts thereof, for example parecoxib sodium, in an amount constitution. therapeutically effective total by about 30% to about 90% by weight, (b) a parenterally acceptable buffering agent in an amount from about 5% to about 60% by weight, and optionally (c) other parenterally excipient ingredients acceptable in a total amount not greater than about 10% by weight of the composition. The composition is reconstitutable in a parenterally acceptable solvent liquid to form a solution for injection. A lyophilization process is provided for the preparation of such a composition.
机译:“含有cox-2抑制剂的可重构的肠胃外组合物”。药物组合物以粉末形式包含一定量组成的(a)至少一种选自选择性cox-2抑制药物及其前药和盐的水溶性治疗剂,例如帕瑞昔布钠。治疗有效总量为约30%至约90%重量,(b)肠胃外可接受的缓冲剂的量为约5%至约60%重量,和(c)其他肠胃外赋形剂成分的总量为可接受不大于组合物重量的约10%。该组合物在肠胃外可接受的溶剂液体中可重构以形成注射溶液。提供了用于制备这种组合物的冻干方法。

著录项

  • 公开/公告号BR0208652B1

    专利类型

  • 公开/公告日2017-10-31

    原文格式PDF

  • 申请/专利权人 PHARMACIA CORPORATION;

    申请/专利号BR20020208652

  • 发明设计人 AZIZ KARIM;SANDEEP NEMA;TUGRUL T. KARARLI;

    申请日2002-04-02

  • 分类号A61K31/42;C07D237/16;A61K9;A61K9/08;A61K9/19;A61K31;A61K31/122;A61K31/352;A61K31/365;A61K31/415;A61K31/444;A61K31/50;A61K45/08;A61K47/02;A61K47/04;A61K47/12;A61K47/18;A61K47/36;A61P29;C07D213/61;C07D231/12;C07D261/08;C07D307/58;C07D311/58;

  • 国家 BR

  • 入库时间 2022-08-21 13:40:58

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号